A Clark County resident has tested positive for clade I mpox, the more severe strain of the virus, and health officials say the person had no reported travel exposure. The Southern Nevada Health District confirmed the case this week, marking the first time the clade I strain has turned up in a local resident without a clear travel link.
The health district reported the case as part of a broader update on mpox activity in the Las Vegas area, according to KSNV. Since the virus was first detected locally in June 2022, Clark County has logged 365 total mpox cases, according to the Southern Nevada Health District. The district also noted that 11 confirmed clade II cases have surfaced locally between August and October 2026, a sign of increased virus activity heading into the clade I discovery.
No Clear Source of Exposure
SNHD has said the individual diagnosed with clade I mpox has no reported travel exposure, leaving the source of transmission unclear. Dr. Cassius Lockett, the district's health officer, said mpox continues to circulate in the community and encouraged people at risk to get vaccinated and those potentially exposed to seek guidance promptly. Lockett also said that recognizing symptoms early and avoiding close contact with others while sick can help prevent further spread, per the same report from the health district.
Clade I and clade II are the two viral types behind mpox illness. Clade II caused the global outbreak that began in 2022 and continues to circulate at low levels across the U.S., while clade I spread widely across Central and Eastern Africa in 2024 before cases began appearing in other countries, including the United States, the health district's report notes.
Why Clade I Draws Closer Scrutiny
The heightened concern around clade I stems from its track record overseas. According to the Johns Hopkins Bloomberg School of Public Health, clade I mpox has historically produced case fatality rates between 1% and 10% in African outbreaks, compared with less than 1% to 4% for clade II. The World Health Organization declared clade I a Public Health Emergency of International Concern in August 2024 amid a rapid surge of the clade Ib strain across Central and Eastern Africa, its second such mpox declaration.
Clade I's arrival in the U.S. has followed a steady progression. The first known American case was confirmed in a traveler returning from Eastern Africa to California in November 2024, according to the Centers for Disease Control and Prevention. Nearly a year later, in October 2025, Long Beach, California recorded the nation's first locally acquired clade I case in a patient with no travel history, as reported by CIDRAP. Similar travel-linked and non-travel cases have since surfaced elsewhere, including in Arizona and San Diego County.
Vaccine and Exposure Guidance
Health officials emphasize that the Jynneos vaccine is expected to protect against both clade I and clade II mpox, and SNHD continues to offer it at its immunization clinics. By August 2024, clinics affiliated with the health district had already administered more than 11,740 doses across Clark County, reflecting the scale of earlier vaccination efforts following the 2022 outbreak.
The standard Jynneos regimen for adults 18 and older requires two doses spaced four weeks, or 28 days, apart to achieve full protection, according to the Centers for Disease Control and Prevention. For those who may have been exposed, the agency says post-exposure vaccination works best within four days of exposure, though getting the shot between four and 14 days afterward can still reduce how severe symptoms become. Anyone potentially exposed should monitor for symptoms for 21 days following their last contact, per SNHD guidance.
How Mpox Spreads and What Symptoms Look Like
Mpox spreads primarily through close, sustained physical contact, including direct contact with rash, sores, scabs or bodily fluids, as well as through kissing or oral, anal or vaginal sex. It can also spread through contaminated clothing, bedding or towels, and through pregnancy or childbirth. Symptoms usually begin within three weeks of exposure and the illness typically lasts two to four weeks, with a rash that may appear on or near the genitals or anus, or on the hands, feet, chest, face or mouth.
Other symptoms can include fever, chills, swollen lymph nodes, headache, muscle aches and fatigue, though some people develop only a rash without any other symptoms. Anyone with suspected or confirmed mpox is advised to stay home and avoid close contact with others, including household members and pets, and to avoid sexual contact, kissing and other close physical contact. If contact with others is unavoidable, health officials recommend wearing a well-fitting mask and completely covering rashes and sores with clothing or bandages.
People with mpox should also avoid sharing clothing, bedding, towels and other personal items, and should wash their hands frequently with soap and water, especially after touching the rash, using an alcohol-based hand sanitizer when soap and water aren't available. Isolation should continue until all sores have healed, scabs have fallen off and a fresh layer of skin has formed, per the health district's guidance.
